Aurinia Pharmaceuticals Inc. (AUPH)
Data as of , from SEC Form 4 filings.
See up to 3 months of AUPH. The 7-day demo opens the 1M and 3M ranges and puts AUPH on your watchlist.
Start 7-day demoLatest AUPH insider trades
About Aurinia Pharmaceuticals Inc. (AUPH)
The SEC lists Aurinia Pharmaceuticals Inc. under CIK 0001600620, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
AUPH Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 32,914 | $546K |
AUPH insider transactions (Form 4)
1235 Form 4 filings on record, the earliest from Nov 12, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David R.W. Jayne - Director | Grant or award | Common Shares | 12,135 | $0.00 | - | |
| David R.W. Jayne - Director | Grant or award | Director Stock Option (right to buy) | 18,641 | $0.00 | - | |
| Jeffrey Allen Bailey - Director | Grant or award | Common Shares | 12,135 | $0.00 | - | |
| Jeffrey Allen Bailey - Director | Grant or award | Director Stock Option (right to buy) | 18,641 | $0.00 | - | |
| Craig A. Johnson - Director | Grant or award | Common Shares | 20,631 | $0.00 | - | |
| Craig A. Johnson - Director | Grant or award | Director Stock Option (right to buy) | 31,688 | $0.00 | - | |
| Karen L. Smith - Director | Option exercise | Common Stock | 17,913 | - | - | |
| Karen L. Smith - Director | Open-market sale | Common Stock | 5,241 | $8.43 | $44K | |
| Karen L. Smith - Director | Option exercise | Restricted Stock Units | 17,913 | $0.00 | - | |
| Jeffrey Allen Bailey - Director | Option exercise | Common Stock | 17,913 | - | - | |
| Jeffrey Allen Bailey - Director | Open-market sale | Common Stock | 4,557 | $8.43 | $38K | |
| Jeffrey Allen Bailey - Director | Option exercise | Restricted Stock Units | 17,913 | $0.00 | - |
Recent AUPH Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Stephen P. Robertson | Officer | 47,000 | $719K | View on EDGAR | |
| - | - | - | - |
AUPH insider trading FAQ
What is the latest insider trade for AUPH?
Aurinia Pharmaceuticals Inc. (AUPH) had 2 insider filings in the last 90 days, with the most recent on 2026-09-11. The full record for AUPH runs to 35 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AUPH stock?
No insider purchases of AUPH were filed in the last 90 days. 17 purchases are on record for this company.
How many insiders are selling AUPH stock?
2 insider sales of AUPH were filed in the last 90 days, totaling $546K.
Where can I see AUPH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AUPH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Stephen P. Robertson view on EDGAR
- - Stephen P. Robertson view on EDGAR
- - Craig A. Johnson view on EDGAR
- - Kathleen Goetz view on EDGAR
- - Tina Susan Nova view on EDGAR
- - Jeffrey Allen Bailey view on EDGAR
- - Kevin Tang view on EDGAR
- - Stephen P. Robertson view on EDGAR
- - Michael S. Hearne view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where AUPH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AUPH with a 7-day demo
- AUPH on your watchlist
- Every AUPH Form 4 filing on record
- Up to 3 months of AUPH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
